This site is intended for healthcare professionals only

Cardiovascular disease

Filter:

New-onset diabetes and statin therapy
Adding up the evidence: Intensive glycaemic control and cardiovascular risk
Are different insulin formulations and regimens associated with different CV risk profiles?
Can improvements in primary care reduce diabetes-related hospitalisations?
A randomised trial of therapies for type 2 diabetes and coronary artery disease: The BARI-2D study
Judicious use of ACE inhibitors: No time to waste?
Cardiovascular risk in people with metabolic syndrome and diabetes
Hyperglycaemia and coronary heart disease: The meta picture
Don’t throw the baby out with the bath water! The effect of the Quality and Outcomes Framework on UK diabetes care
A role for retinopathy in predicting cardiovascular disease
Cardiovascular disease, type 2 diabetes and the metabolic syndrome: Effects of fenofibrate treatment
Risk calculation: An important part of diabetes care
Implementing the NHS Health Checks programme
Cardiovascular disease risk estimation: Why, when and how?
Intensive glucose-lowering and cardiovascular disease
Controlling hyperglycaemia and cardiovascular benefit: The story continues
Influence of hyperglycaemia on stroke outcomes
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.